predict disease severity in asthma. These results indicate that for most indoor allergens, allergen-specific IgE levels might be a marker of allergen exposure and disease burden.
METHODS. Survey sites were designated as having or not having at least 1 smoke-free work location, restaurant, or bar law at the county or state level that encompassed the entire county population. Asthma prevalence was assessed as self-reported current asthma and as ever having asthma with current symptoms. Asthmatic symptoms included persistent wheeze, chronic night cough, and wheeze-medication use. The authors also examined asthma severity defined by asthma episode or emergency department visit for asthma.
RESULTS. Smoke-free laws were significantly related with lower odds of asthma symptoms (odds ratio [OR] : 0.67 [95% confidence interval (CI): 0.48 -0.93]) among nonsmoking youth. The relationship between smoke-free laws and ever having asthma with current symptoms trended to significance (OR: 0.74 [95% CI: 0.53-1.03]). Smoke-free laws were associated with lower odds of asthma episodes (OR: 0.66 [95% CI: 0.28 -1.56]) and emergency department visits for asthma (OR: 0.55 [95% CI: 0.27-1.13]), but these outcomes were not statistically significant.
CONCLUSIONS. Smoke-free laws decrease asthma symptoms, including persistent wheeze, chronic nocturnal cough, and wheeze-medication use in youthful nonsmoking populations.
REVIEWER COMMENTS. This study was limited by the countylimited definition of smoke-free laws, which is only an estimate of individual exposure to secondhand tobacco smoke outside the home. Misclassification of county smoke-free laws might not reflect individual exposure, and misclassification of current asthma is possible because self-reports were not validated by objective measures or clinical assessment. However, the findings of this study are consistent with those of other studies of secondhand smoke. In summary, the take-home message and conclusion of this important study is that smoke-free laws are associated with decreased exposure to secondhand smoke but equally with decreased respiratory symptoms as well. To study the independent and joint effects of prenatal smoking and low birth weight (LBW) on childhood asthma.
STUDY POPULATION. The study included asthmatic 11-to 12-year-old children in Sweden (N ϭ 3389).
METHODS. Children were studied by questionnaire survey as part of the International Study of Asthma and Allergy in Childhood (ISAAC). A subset of 2121 children also underwent skin-prick testing.
RESULTS. Mean birth weight was 3360 g in children exposed to prenatal smoking and 3571 g in nonexposed children (P Ͻ .001). The association of prenatal smoking with physician-diagnosed asthma was stronger in LBW children (risk ratio: 8.8 [95% confidence interval: 2.1-38]) than in normal birth weight children (risk ratio: 1.3 [95% confidence interval: 1.0 -1.8]). LBW alone was not an independent predictor of asthma.
CONCLUSIONS. There is a strong interaction of LBW and prenatal smoking on the risk of physician-diagnosed asthma, which is observed even after adjusting for known risk factors including allergic sensitization.
REVIEWER COMMENTS. This report highlights the observation that the combination of LBW and prenatal smoking increases the risk of physician-diagnosed asthma sixfold versus either LBW (no effect) or prenatal smoking (weak effect) alone. The authors speculated that smokeinduced oxidative stress in underdeveloped airways (caused by impaired fetal growth) might lead to increased asthma risk. In this regard, it has been shown that smoke exposure interacts with ADAM33 polymor-phisms in a way that adversely affects lung function and hyperresponsiveness. STUDY POPULATION. Studied were 150 predominantly black children from the east Baltimore, Maryland, area aged 2 to 6 years with physician-diagnosed asthma and symptoms or medication use in the previous 6 months. Most of the children were from lower-income households.
METHODS. Integrated air sampling in the child's bedroom was performed over 3 days at baseline, 3 months, and 6 months, using PM 10 (particulate matter that is Ͻ10 m in diameter) and PM 2.5 (particulate matter that is Ͻ2.5 m in diameter) samples collected with personal environmental monitors. Ambient particulate matter for the study was monitored at a central site within the study area. Each child underwent baseline skin testing to a mix of 14 aeroallergens. Atopy was defined as at least 1 positive skin-test result. At baseline, 3 months, and 6 months, caregivers completed questionnaires adapted from the International Study of Asthma and Allergies in Childhood and the Children's Health Survey for Asthma Questions. Participants completed a daily activity diary during each 3-day monitoring period, including an account of the time spent in the room where monitoring was performed.
RESULTS. Subjects were classified as nonatopic (31%) or atopic (69%). Nonatopic children were slightly younger. Indoor PM 2.5-10 concentrations were similar in atopic and nonatopic children's homes, although PM 2.5 exposure was significantly higher in the homes of children with nonatopic asthma (P ϭ .04). Concentrations of PM 2.5 exceeded Environmental Protection Agency standards in 75% of the homes. There were statistically significant interactions found between both coarse and fine particulate matter levels and asthma symptoms in both atopic and nonatopic asthmatic children.
CONCLUSIONS. In-home particle concentrations are associated with asthma morbidity, including symptoms and use of rescue medications, among atopic and nonatopic children with asthma. Strategies for reducing and eliminating sources of indoor particulate matter pollution should be considered a priority in the management of nonatopic asthma.
REVIEWER COMMENTS. This study is one of few to note that the effect of indoor air pollution is at least as important in nonatopic children with asthma. As clinicians, we often discuss secondhand smoke, which is a component of indoor particulate matter, but we also should consider other sources including cooking and cleaning products. 
